Altre lingue Novonesis A/S

Azioni

Mercato chiuso - Nasdaq Copenhagen Altri mercati azionari 16:59:45 25/04/2024			Variaz. 5gg	Var. 1 gen.
384,7 ^DKK	-0,82%		+0,52%	+3,66%

26/03	La Cina accelererà le 'nuove forze produttive', dice il Vicepresidente	RE
21/03	Transcript : Novozymes A/S, 2024 Guidance/Update Call, Mar 21, 2024

Novonesis A/S : Invitation to the annual shareholders' meeting	08/04
Invitation to the annual shareholders’ meeting	08/04
Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023	08/04
Share-based legacy RSU program granted	08/04
China to speed up 'new productive forces', vice president says	26/03
Fed en Argenx helpen Brusselse beurs aan winst	24/03
Nordic Shares Rose Thursday; Embracer Group Series B Topped Leaders	21/03
Novonensis expects 2024 adjusted EBITDA margin of 35%	21/03
2024 outlook and pro forma financials	21/03
2024 outlook and pro forma financials	21/03
Novonesis Provides Earnings Guidance for the Year 2024	21/03
Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development	18/03
Argenx en nieuwkomers zorgen voor rood slot Bel20	18/03
Novonesis will host a conference call regarding 2024 outlook and 2023 pro forma financials on March 21	18/03
Pas op de plaats voor Bel20 ondanks koerswinst UCB	18/03
Biotalys uitblinker in Brussel	18/03
Brussel start handelsweek vermoedelijk licht hoger	18/03
Biotalys in zee met Novonesis voor Evoca	18/03
Biotalys and Novonesis Announces Manufacturing and Commercialization Partnership for EVOCA NG	18/03
FMC Partners With Novonesis in Canada for Biosolution Products	12/03

Non ci sono risultati per questa ricerca

NOVOZYMES : Q4 23: il rumore del destocking compensa la ripresa di altri segmenti chiave

08 febbraio 2024 alle 15:18